Vital Healthcare Property (VTHPF) Ratios
Vital Healthcare Property Ratios
VTHPF's free cash flow for Q4 2026 was $46.69M. For the 2026 fiscal year, VTHPF's free cash flow was increased by $0.00 and operating cash flow was $46.69M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 15.38 | 1.65 | 1.43 | 2.22 | 1.03 |
| Quick Ratio | 15.38 | 1.65 | 1.43 | 0.43 | 1.03 |
| Cash Ratio | 8.79 | 0.37 | 0.46 | 0.21 | 0.57 |
| Solvency Ratio | -0.01 | -0.03 | -0.07 | -0.09 | 0.26 |
| Operating Cash Flow Ratio | 54.23 | 1.63 | 1.48 | 1.42 | 1.57 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 650.40 |
| Net Current Asset Value | $ -1.64B | $ -1.50B | $ -1.44B | $ -1.36B | $ -1.19B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.42 | 0.39 | 0.36 | 0.30 |
| Debt-to-Equity Ratio | 0.74 | 0.82 | 0.72 | 0.64 | 0.47 |
| Debt-to-Capital Ratio | 0.43 | 0.45 | 0.42 | 0.39 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.45 | 0.42 | 0.39 | 0.32 |
| Financial Leverage Ratio | 1.86 | 1.93 | 1.83 | 1.75 | 1.57 |
| Debt Service Coverage Ratio | 0.56 | -0.09 | 1.47 | -2.99 | 11.36 |
| Interest Coverage Ratio | 3.01 | 2.63 | 2.66 | -2.55 | 13.41 |
| Debt to Market Cap | 0.98 | 1.05 | 1.08 | 0.81 | 0.66 |
| Interest Debt Per Share | 1.98 | 2.10 | 2.00 | 1.95 | 1.84 |
| Net Debt to EBITDA | 242.26 | -1532.60 | 20.26 | -12.65 | 2.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 79.32% | 74.07% | 71.01% | 65.20% | 63.61% |
| EBIT Margin | 3.03% | -0.50% | 37.38% | -56.86% | 272.55% |
| EBITDA Margin | 3.03% | -0.50% | 37.38% | -56.86% | 272.55% |
| Operating Profit Margin | 86.38% | 69.55% | 68.19% | -56.86% | 272.55% |
| Pretax Profit Margin | -25.70% | -26.99% | -64.11% | -79.17% | 252.22% |
| Net Profit Margin | -12.75% | -28.92% | -63.76% | -88.96% | 211.32% |
| Continuous Operations Profit Margin | -12.75% | -28.92% | -63.76% | -88.96% | 211.32% |
| Net Income Per EBT | 49.63% | 107.17% | 99.45% | 112.37% | 83.78% |
| EBT Per EBIT | -29.75% | -38.80% | -94.01% | 139.23% | 92.54% |
| Return on Assets (ROA) | -0.69% | -1.58% | -3.26% | -4.44% | 8.93% |
| Return on Equity (ROE) | -1.27% | -3.05% | -5.96% | -7.79% | 14.01% |
| Return on Capital Employed (ROCE) | 4.64% | 3.84% | 3.53% | -2.88% | 11.65% |
| Return on Invested Capital (ROIC) | 2.30% | 3.84% | 3.51% | -2.88% | 9.76% |
| Return on Tangible Assets | -0.69% | -1.58% | -3.26% | -4.44% | 8.93% |
| Earnings Yield | -1.71% | -3.93% | -9.04% | -9.92% | 19.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 18.78 | 53.38 | 16.42 | 29.62 | 58.82 |
| Payables Turnover | 1.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.64 | 2090.64 |
| Fixed Asset Turnover | 925.56 | 0.06 | 0.05 | 0.05 | 0.04 |
| Asset Turnover | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Working Capital Turnover Ratio | 7.82 | 7.88 | 4.16 | 5.29 | -1.95 |
| Cash Conversion Cycle | -337.68 | 6.84 | 22.23 | 580.90 | 6.38 |
| Days of Sales Outstanding | 19.44 | 6.84 | 22.23 | 12.32 | 6.21 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 568.58 | 0.17 |
| Days of Payables Outstanding | 357.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 19.44 | 6.84 | 22.23 | 580.90 | 6.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.11 | 0.10 | 0.09 | 0.11 | 0.11 |
| Free Cash Flow Per Share | 0.11 | 0.10 | 0.09 | 0.11 | 0.11 |
| Dividend Paid and CapEx Coverage Ratio | 1.45 | 1.14 | 1.07 | 1.45 | 1.93 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.44 | 0.39 | 0.36 | 0.43 | 0.42 |
| Free Cash Flow Yield | 5.87% | 5.24% | 5.16% | 4.79% | 3.94% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -58.54 | -25.46 | -11.06 | -10.08 | 5.06 |
| Price-to-Sales (P/S) Ratio | 7.46 | 7.37 | 7.05 | 8.96 | 10.70 |
| Price-to-Book (P/B) Ratio | 0.74 | 0.78 | 0.66 | 0.78 | 0.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.03 | 19.07 | 19.37 | 20.87 | 25.40 |
| Price-to-Operating Cash Flow Ratio | 17.03 | 19.07 | 19.37 | 20.87 | 25.40 |
| Price-to-Earnings Growth (PEG) Ratio | 1.03 | 0.48 | 0.36 | 0.07 | -0.95 |
| Enterprise Value Multiple | 488.47 | -3004.93 | 39.13 | -28.41 | 6.47 |
| Enterprise Value | 2.88B | 2.66B | 2.47B | 2.77B | 2.53B |
| EV to EBITDA | 488.47 | -3004.93 | 39.13 | -28.41 | 6.47 |
| EV to Sales | 14.81 | 15.03 | 14.63 | 16.16 | 17.63 |
| EV to Free Cash Flow | 33.78 | 38.92 | 40.18 | 37.61 | 41.85 |
| EV to Operating Cash Flow | 33.78 | 38.92 | 40.18 | 37.61 | 41.85 |
| Tangible Book Value Per Share | 2.58 | 2.48 | 2.70 | 2.98 | 3.81 |
| Shareholders’ Equity Per Share | 2.58 | 2.48 | 2.70 | 2.98 | 3.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.50 | -0.07 | 0.01 | -0.12 | 0.16 |
| Revenue Per Share | 0.26 | 0.26 | 0.25 | 0.26 | 0.25 |
| Net Income Per Share | -0.03 | -0.08 | -0.16 | -0.23 | 0.53 |
| Tax Burden | 0.50 | 1.07 | 0.99 | 1.12 | 0.84 |
| Interest Burden | -8.48 | 53.94 | -1.71 | 1.39 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.09 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.09 | 0.11 |
| Income Quality | -3.44 | -1.34 | -0.57 | -0.48 | 0.20 |
Currency in NZD